TY - JOUR AU - Chen, D. S. AU - Mellman, I. PY - 2013 DA - 2013// TI - Oncology meets immunology: the cancer-immunity cycle JO - Immunity VL - 39 UR - https://doi.org/10.1016/j.immuni.2013.07.012 DO - 10.1016/j.immuni.2013.07.012 ID - Chen2013 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - McDermott, D. F. AU - George, S. AU - Hammers, H. J. PY - 2015 DA - 2015// TI - Nivolumab versus Everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510665 DO - 10.1056/NEJMoa1510665 ID - Motzer2015 ER - TY - STD TI - NCCN Clinical Practice Guidelines in Oncology, https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf; [accessed 8 May 2019] 2019. UR - https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf ID - ref3 ER - TY - STD TI - European Association of Urology Renal Cell Carcinoma Guidelines, https://uroweb.org/guideline/renal-cell-carcinoma/#7; [accessed 8 May 2019] 2019. UR - https://uroweb.org/guideline/renal-cell-carcinoma/#7; ID - ref4 ER - TY - JOUR AU - Heng, D. Y. AU - Xie, W. AU - Regan, M. M. AU - Harshman, L. C. AU - Bjarnason, G. A. AU - Vaishampayan, U. N. PY - 2013 DA - 2013// TI - External validation and comparison with other models of the international metastatic renal-cell carcinoma database consortium prognostic model: a population-based study JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(12)70559-4 DO - 10.1016/S1470-2045(12)70559-4 ID - Heng2013 ER - TY - JOUR AU - Motzer, R. J. AU - Bacik, J. AU - Murphy, B. A. AU - Russo, P. AU - Mazumdar, M. PY - 2002 DA - 2002// TI - Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.20.1.289 DO - 10.1200/JCO.2002.20.1.289 ID - Motzer2002 ER - TY - JOUR AU - Templeton, A. J. AU - McNamara, M. G. AU - Šeruga, B. AU - Vera-Badillo, F. E. AU - Aneja, P. AU - Ocaña, A. PY - 2014 DA - 2014// TI - Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis JO - J Natl Cancer Inst VL - 106 UR - https://doi.org/10.1093/jnci/dju124 DO - 10.1093/jnci/dju124 ID - Templeton2014 ER - TY - JOUR AU - Qi, Q. AU - Zhuang, L. AU - Shen, Y. AU - Geng, Y. AU - Yu, S. AU - Chen, H. PY - 2016 DA - 2016// TI - A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.30057 DO - 10.1002/cncr.30057 ID - Qi2016 ER - TY - JOUR AU - Mbeutcha, A. AU - Shariat, S. F. AU - Rieken, M. AU - Rink, M. AU - Xylinas, E. AU - Seitz, C. PY - 2016 DA - 2016// TI - Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer JO - Urol Oncol VL - 34 UR - https://doi.org/10.1016/j.urolonc.2016.05.013 DO - 10.1016/j.urolonc.2016.05.013 ID - Mbeutcha2016 ER - TY - JOUR AU - Ramsey, S. AU - Lamb, G. W. AU - Aitchison, M. AU - McMillan, D. C. PY - 2008 DA - 2008// TI - Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer JO - BJU Int VL - 101 UR - https://doi.org/10.1111/j.1464-410X.2007.07363.x DO - 10.1111/j.1464-410X.2007.07363.x ID - Ramsey2008 ER - TY - JOUR AU - Ohno, Y. AU - Nakashima, J. AU - Ohori, M. AU - Gondo, T. AU - Hatano, T. AU - Tachibana, M. PY - 2012 DA - 2012// TI - Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma JO - J Urol VL - 187 UR - https://doi.org/10.1016/j.juro.2011.10.026 DO - 10.1016/j.juro.2011.10.026 ID - Ohno2012 ER - TY - JOUR AU - Martino, M. AU - Pantuck, A. J. AU - Hofbauer, S. AU - Waldert, M. AU - Shariat, S. F. AU - Belldegrun, A. S. PY - 2013 DA - 2013// TI - Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma JO - J Urol VL - 190 UR - https://doi.org/10.1016/j.juro.2013.06.082 DO - 10.1016/j.juro.2013.06.082 ID - Martino2013 ER - TY - JOUR AU - Viers, B. R. AU - Houston Thompson, R. AU - Boorjian, S. A. AU - Lohse, C. M. AU - Leibovich, B. C. AU - Tollefson, M. K. PY - 2014 DA - 2014// TI - Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy JO - Urol Oncol VL - 32 UR - https://doi.org/10.1016/j.urolonc.2014.05.014 DO - 10.1016/j.urolonc.2014.05.014 ID - Viers2014 ER - TY - JOUR AU - Boissier, R. AU - Campagna, J. AU - Branger, N. AU - Karsenty, G. AU - Lechevallier, E. PY - 2017 DA - 2017// TI - The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: a review JO - Urol Oncol VL - 35 UR - https://doi.org/10.1016/j.urolonc.2017.01.016 DO - 10.1016/j.urolonc.2017.01.016 ID - Boissier2017 ER - TY - JOUR AU - Hu, K. AU - Lou, L. AU - Ye, J. AU - Zhang, S. PY - 2015 DA - 2015// TI - Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2014-006404 DO - 10.1136/bmjopen-2014-006404 ID - Hu2015 ER - TY - JOUR AU - Chrom, P. AU - Stec, R. AU - Semeniuk-Wojtas, A. AU - Bodnar, L. AU - Spencer, N. J. AU - Szczylik, C. PY - 2016 DA - 2016// TI - Fuhrman grade and neutrophil-to-lymphocyte ratio influence on survival in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors JO - Clin Genitourin Cancer VL - 14 UR - https://doi.org/10.1016/j.clgc.2016.02.005 DO - 10.1016/j.clgc.2016.02.005 ID - Chrom2016 ER - TY - JOUR AU - Templeton, A. J. AU - Knox, J. J. AU - Lin, X. AU - Simantov, R. AU - Xie, W. AU - Lawrence, N. PY - 2016 DA - 2016// TI - Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.02.033 DO - 10.1016/j.eururo.2016.02.033 ID - Templeton2016 ER - TY - JOUR AU - Jeyakumar, G. AU - Kim, S. AU - Bumma, N. AU - Landry, C. AU - Silski, C. AU - Suisham, S. PY - 2017 DA - 2017// TI - Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy JO - J Immunother Cancer VL - 5 UR - https://doi.org/10.1186/s40425-017-0287-5 DO - 10.1186/s40425-017-0287-5 ID - Jeyakumar2017 ER - TY - JOUR AU - Lalani, A. A. AU - Xie, W. AU - Martini, D. J. AU - Steinharter, J. A. AU - Norton, C. K. AU - Krajewski, K. M. PY - 2018 DA - 2018// TI - Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0315-0 DO - 10.1186/s40425-018-0315-0 ID - Lalani2018 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - STD TI - Galdiero MR, Marone G, Mantovani A. Cancer inflammation and cytokines. Cold Spring Harb Perspect Biol. 2018;10. pii: a028662. ID - ref21 ER - TY - JOUR AU - Kobayashi, M. AU - Kubo, T. AU - Komatsu, K. AU - Fujisaki, A. AU - Terauchi, F. AU - Natsui, S. PY - 2013 DA - 2013// TI - Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-013-0556-1 DO - 10.1007/s12032-013-0556-1 ID - Kobayashi2013 ER - TY - STD TI - Lingyun Wu, Sugandha Saxena, Mohammad Awaji and Rakesh K. Singh. Tumor-associated neutrophils in cancer: going pro. Cancers (Basel). 2019;11:pii: E564. ID - ref23 ER - TY - JOUR AU - Ohno, Y. AU - Nakashima, J. AU - Ohori, M. AU - Tanaka, A. AU - Hashimoto, T. AU - Gondo, T. PY - 2014 DA - 2014// TI - Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status JO - Int J Clin Oncol VL - 19 UR - https://doi.org/10.1007/s10147-012-0514-5 DO - 10.1007/s10147-012-0514-5 ID - Ohno2014 ER - TY - JOUR AU - Cetin, B. AU - Berk, V. AU - Kaplan, M. A. AU - Afsar, B. AU - Tufan, G. AU - Ozkan, M. PY - 2013 DA - 2013// TI - Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma? JO - Clin Genitourin Cancer VL - 11 UR - https://doi.org/10.1016/j.clgc.2012.09.001 DO - 10.1016/j.clgc.2012.09.001 ID - Cetin2013 ER - TY - JOUR AU - Fox, P. AU - Hudson, M. AU - Brown, C. AU - Lord, S. AU - Gebski, V. AU - Souza, P. AU - Lee, C. K. PY - 2013 DA - 2013// TI - Markers of systemic inflammation predict survival in patients with advanced renal cell cancer JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.300 DO - 10.1038/bjc.2013.300 ID - Fox2013 ER -